Sign In
Buy DGNOF
$0.158
-0.0041 (-2.54%)
At Close: Jun 03, 2026
Comparing SAIHEAT (NASDAQ:SAIH) and DIAGNOS (OTCMKTS:DGNOF)
01:47am, Monday, 03'rd Nov 2025
SAIHEAT (NASDAQ: SAIH - Get Free Report) and DIAGNOS (OTCMKTS:DGNOF - Get Free Report) are both small-cap business services companies, but which is the superior investment? We will compare the two bus
DIAGNOS (OTCMKTS:DGNOF) Trading Down 4.3% – Should You Sell?
02:52am, Friday, 24'th Oct 2025
DIAGNOS Inc. (OTCMKTS:DGNOF - Get Free Report) shares dropped 4.3% during trading on Thursday. The company traded as low as $0.22 and last traded at $0.23. Approximately 25,000 shares were traded duri
DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on November 9, 2025
03:00pm, Wednesday, 22'nd Oct 2025
BROSSARD, Quebec, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health i
DIAGNOS to Present at the Centurion One Capital 3rd Annual Bahamas Summit
09:34am, Wednesday, 15'th Oct 2025
Brossard, Quebec--(Newsfile Corp. - October 15, 2025) - Diagnos Inc. (TSXV: ADK) (OTCQB: DGNOF) (FSE: 4D4A) ("DIAGNOS" or the "Corporation"), a pioneer in early detection of critical health issues us
DIAGNOS Announces Voting Results of Meeting of Shareholders
03:30pm, Thursday, 25'th Sep 2025
BROSSARD, Quebec, Sept. 25, 2025 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health
DIAGNOS Announces Closing of Private Placement
03:45pm, Friday, 05'th Sep 2025
BROSSARD, Quebec, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health
DIAGNOS to Extend Stock Warrants Exercise Period
10:15am, Friday, 15'th Aug 2025
BROSSARD, Quebec, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health i
DIAGNOS Announces Extension of Stock Warrants Exercise Period
12:01pm, Wednesday, 13'th Aug 2025
BROSSARD, Quebec, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health i
DIAGNOS Welcomes Founder of National Vision Associates, Ed Weiner, to its Advisory Board for the United States
11:46am, Tuesday, 10'th Jun 2025
BROSSARD, Quebec, June 10, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health i
DIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market
06:30am, Wednesday, 04'th Jun 2025
BROSSARD, Quebec, June 04, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health i
DIAGNOS Announces the Engagement of Allele Capital Partners
12:02pm, Friday, 23'rd May 2025
BROSSARD, Quebec, May 23, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health is
DIAGNOS Announces Amendment to Convertible Debentures
03:15pm, Tuesday, 20'th May 2025
BROSSARD, Quebec, May 20, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health is
BROSSARD, Quebec, April 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalm
DIAGNOS Provides Additional Information on Amendment to Convertible Debentures
03:45pm, Monday, 14'th Apr 2025
BROSSARD, Quebec, April 14, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalm
DIAGNOS Provides Update on its Health Canada Medical Device Licence Application
06:30am, Wednesday, 09'th Apr 2025
BROSSARD, Quebec, April 09, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of certain ophthalm
